已收盤 11-20 16:00:00 美东时间
-0.280
-0.31%
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
11-20 19:12
11月19日,BillionToOne(BLLN)收跌6.11%,报91.54美元,成交额1.31亿美元,市值43.73亿美元。 行情数据 • 开盘价:93....
11-19 06:09
BillionToOne, Inc. has responded to a report by Fuzzy Panda Research, a short seller, which it claims contains inaccurate and misleading information. The company rejects the report's conclusions, emphasizing its commitment to business integrity, test quality, and regulatory compliance. BillionToOne is reviewing the report with legal advisors to explore potential legal actions. The company remains focused on serving patients, providers, and shareh...
11-18 21:05
BillionToOne, Inc., a molecular diagnostics company, announced that its management will participate in the Piper Sandler 38th Annual Healthcare Conference with a fireside chat on December 1, 2026, from 3:00pm to 3:25pm ET. A live and archived webcast will be available on the company's investor relations website. BillionToOne specializes in creating accessible, powerful, and accurate molecular tests using its patented QCT™ technology for single-mo...
11-18 13:05
11月13日,BillionToOne(BLLN)收涨0.51%,报110.79美元,成交额6345.88万美元,市值52.93亿美元。 行情数据 • 开盘价...
11-13 06:07
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
今日重点评级关注:Citizens:维持Precigen"跑赢大市"评级,目标价从11美元升至12美元;Leerink Partners:维持Arcus Biosciences"跑赢大市"评级,目标价从46美元升至49美元
11-06 16:15
11月6日,BillionToOne(BLLN)收跌1.32%,报112.39美元,成交额1.82亿美元,市值53.03亿美元。 行情数据 • 开盘价:101...
11-06 06:04
BTIG analyst Mark Massaro reiterates BillionToOne (NASDAQ:BLLN) with a Buy and maintains $130 price target.
11-05 19:08
BillionToOne (NASDAQ:BLLN) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.28 by 14.29 percent. This is a 190.91 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $122.981 million w...
11-05 06:46